NIH-Led Team Advances HIV Vaccine Design with Specially Shaped Protein
An HIV vaccine research team led by scientists from the National Institutes of Health has engineered a protein to maintain the particular shape predicted to be most effective at stimulating the immune system to produce powerful antibodies against the virus. The work was led by John R. Mascola, M.D., and Peter D. Kwong, Ph.D., of the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH.
This page was last updated on Friday, January 21, 2022